Filter
3201
Filtered Results: 3201
Text search:
The
Lancet
Global
Health
Featured
Recommendations
244
New Publications
546
Language
Document type
No document type
1465
Studies & Reports
922
Guidelines
408
Manuals
127
Strategic & Response Plan
100
Fact sheets
78
Training Material
52
Situation Updates
21
Infographics
15
Resource Platforms
7
Brochures
3
Online Courses
2
Videos
1
Countries / Regions
Global
211
India
77
Latin America and the Carribbean
73
Western and Central Europe
71
South Africa
69
Africa
63
Kenya
58
Brazil
55
Russia
55
Ethiopia
54
Eastern Europe
45
Nigeria
42
Sierra Leone
40
Malawi
37
Liberia
32
Ukraine
31
Uganda
30
Germany
30
Zambia
30
Mozambique
29
Nepal
27
Congo, Democratic Republic of
26
Senegal
25
Syria
24
Rwanda
24
Asia
24
Bangladesh
22
Guinea
21
Ghana
21
Tanzania
21
South–East Asia Region
19
Burkina Faso
17
Zimbabwe
17
East and Southern Africa
17
West and Central Africa
17
Middle East and North Africa
17
Philippines
16
Myanmar / Burma
16
Cameroon
15
Colombia
15
Yemen
15
Eastern Europe and Central Asia
15
Venezuela
15
Chile
14
Haiti
13
Indonesia
13
Mali
11
Benin
11
Angola
11
South Sudan
10
Botswana
10
Madagascar
10
Lesotho
10
Cambodia
9
Namibia
9
Peru
9
Argentina
8
Eswatini/ Swaziland
8
Ecuador
8
Paraguay
8
North America
8
Spain
8
Somalia
7
Sudan
7
Western Pacific Region
7
Vietnam
7
Guinea-Bissau
6
Côte d’Ivoire / Ivory Coast
6
Pakistan
6
Afghanistan
6
Niger
5
Chad
5
Thailand
5
China
5
Mexico
5
Portugal
5
Iraq
4
Jordan
4
El Salvador
4
Italy
4
Albania
4
Southern Africa
4
Tajikistan
4
France
4
United Kingdom
4
USA
3
Lebanon
3
Central African Republic
3
Burundi
3
Bolivia
3
Sri Lanka
3
Laos
3
Kyrgyzstan
3
Kazakhstan
3
Belarus
3
Israel
3
Turkey
2
Egypt
2
Honduras
2
Guatemala
2
Nicaragua
2
Palestine
2
Armenia
2
Congo-Brazzaville
2
Qatar
2
Romania
2
Moldova
2
Uruguay
2
Jamaica
2
Morocco
1
Saudi Arabia
1
Mauritania
1
Dominican Republic
1
North Macedonia
1
Switzerland
1
Hungary
1
Cuba
1
Greece
1
Libya
1
Poland
1
Canada
1
Timor Leste/ East Timor
1
Estonia
1
Lithuania
1
Slovakia
1
Georgia
1
Gabon
1
Japan
1
Denmark
1
Belgium
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
866
Clinical Guidelines
307
Public Health
218
Women & Child Health
207
Key Resources
91
Capacity Building
32
Pharmacy & Technologies
29
Toolboxes
COVID-19
405
HIV
314
Mental Health
278
TB
237
Planetary Health
195
NCDs
135
AMR
115
NTDs
105
Caregiver
95
Global Health Education
92
Health Financing Toolbox
79
Disability
74
Ebola
63
Rapid Response
61
Refugee
44
Conflict
38
Zika
29
Pharmacy
25
Cholera
18
Polio
16
Natural Hazards
13
Social Ethics
6
Health Financing
2
Specific Hazards
1
In this review, the editors will investigate the impact of eight WASH interventions in preventing (reducing the risk of) and controlling outbreaks ...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to ... extensive use of quinolones for treating several types of infections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
This brief summarises key considerations about the social, political and economic context of Goma in relation to the outbreak of Ebola in the DRC a...
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of
risk related to migrants’ country of origin. We assess the performance of a large screening progra...
To identify and to assess factors enhancing or hindering the delivery of breast and cervical cancer screening services in Malawi with regard to accessibility, uptake, acceptability and effectiveness.
Systematic review of published scientific eviden...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces t... term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 infection. According to the new requirements ‘HTLV-1 antibody testing must be performed for donors living in, or originating from high-prevalence areas or with sexual partners originating from those areas or where the donor’s parents originate from those areas’ and this applies to both donors of non-reproductive tissues and cells and reproductive cells.
ECDC contracted experts from the Institut Pasteur in Paris to systematically review the published evidence on the distribution of HTLV-1 infection prevalence throughout the world and to identify high-prevalence countries and areas.
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces t... term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 infection. According to the new requirements ‘HTLV-1 antibody testing must be performed for donors living in, or originating from high-prevalence areas or with sexual partners originating from those areas or where the donor’s parents originate from those areas’ and this applies to both donors of non-reproductive tissues and cells and reproductive cells.
ECDC contracted experts from the Institut Pasteur in Paris to systematically review the published evidence on the distribution of HTLV-1 infection prevalence throughout the world and to identify high-prevalence countries and areas.
With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those inf...
This study aimed to estimate the proportion of Mozambicans eligible for pharmacological treatment for hypertension according to single risk factor and total cardiovascular risk approaches. It concluded that a total of 19.8% of 40–64-year-olds woul...
Supplement October 2010
HIV/AIDS, security and conflict: making the connections
Submitted to the United Nation's Committee on the Convention on the Elimination
of All Forms of Discrimination Against Women
February 2016
P...
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nC...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications abo...
Because of the limited access to more powerful diagnostic tools, there is a paucity of data regarding the burden of fungal infections in Burkina Faso. The... aim of this study was to estimate the incidence and prevalence of serious fungal infections in this sub-Saharan country. We primarily used the national demographic data and performed a PubMed search to retrieve all published papers on fungal infections from Burkina Faso and its surrounding West African countries. Considering the prevalence of HIV infection (0.8% of the population) and a 3.4% incidence of cryptococcosis in hospitals, it is estimated that 459 patients per year develop cryptococcosis. For pneumocystosis, it is suggested that 1013 new cases occur every year. Taking into account the local TB frequency (population prevalence at 0.052%), we estimate the prevalence of chronic pulmonary aspergillosis at 1120 cases. Severe forms of asthma with fungal sensitization and allergic bronchopulmonary aspergillosis are estimated to affect 7429 and 5628 cases, respectively. Vulvovaginal candidiasis may affect 179,000 women, and almost 1,000,000 children may suffer from tinea capitis. Globally, we estimate that roughly 1.4 million people in Burkina Faso (7.51% of the population) suffer from a serious fungal infection. These data should be used to drive future epidemiological studies, diagnostic approaches, and therapeutic strategies.
Covid-19 Epidemiological Surveillance Guide: Public Health Emergency of National Importance for Coronavirus Disease 2019 - version 4
This profile is part of a series of Climate Risk Country Profiles developed by the World Bank Group (WBG). The country profile
synthesizes most relevant data and information on climate change, disa...
Getting to know cerebral palsy
recommended
Working with parent groups – a training resource for facilitators, parents, caregivers, and persons with cerebral palsy.
TThis manual aims to increase knowledge and skills in caring for a child with cerebral palsy. Research highlighted the signif...
Analysis of fake news disseminated during the COVID-19 pandemic in Brazil
This paper aims to explore the conditions needed for sustainable community based rehabilitation (CBR) programmes for persons with disabilities in Vietnam, and to identify the conditions and opportun...
Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной...
